DeepMed Research

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat

Not Applicable

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2016-03-11

Lead Sponsor: NYU Langone Health

Registration Number: NCT00012168

Locations: 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma

Phase 2

Withdrawn

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2003-01-27

Last Posted Date: 2015-08-05

Lead Sponsor: NYU Langone Health

Registration Number: NCT00006263

Locations: 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-01-27

Last Posted Date: 2012-11-09

Lead Sponsor: NYU Langone Health

Registration Number: NCT00005990

Locations: 🇺🇸
NYU Cancer Institute at New York University Medical Center, New York, New York, United States

Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2003-01-27

Last Posted Date: 2012-11-09

Lead Sponsor: NYU Langone Health

Registration Number: NCT00025311

Locations: 🇫🇷
CHU Pitie-Salpetriere, Paris, France
🇺🇸
Herbert Irving Comprehensive Cancer Center, New York, New York, United States
🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer
Gastric Cancer
Gastrointestinal Carcinoid Tumor
Gastrointestinal Stromal Tumor
Ovarian Cancer
Peritoneal Cavity Cancer
Small Intestine Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2011-04-06

Lead Sponsor: NYU Langone Health

Target Recruit Count: 45

Registration Number: NCT00005049

Locations: 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer

Phase 2

Completed

Conditions: Gastric Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2011-04-06

Lead Sponsor: NYU Langone Health

Registration Number: NCT00004103

Locations: 🇺🇸
NYU Cancer Institute at New York University Medical Center, New York, New York, United States

Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Phase 1

Completed

Conditions: Fallopian Tube Cancer
Ovarian Cancer
Peritoneal Cavity Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2011-04-05

Lead Sponsor: NYU Langone Health

Registration Number: NCT00006391

Locations: 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1

Completed

Conditions: Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2011-04-05

Lead Sponsor: NYU Langone Health

Registration Number: NCT00010023

Locations: 🇺🇸
NYU Cancer Institute at New York University Medical Center, New York, New York, United States

Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2011-03-28

Lead Sponsor: NYU Langone Health

Registration Number: NCT00006825

Locations: 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer

Not Applicable

Completed

Conditions: Lung Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2011-03-28

Lead Sponsor: NYU Langone Health

Registration Number: NCT00012103

Locations: 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy